Table 2: Characteristics of Exercise Trials (Inspiratory Muscle Training) in HFpEF Patients.
Study | Intervention/Control (n) | EF/NYHA Class | Major Exclusion Criteria | Session Time/Frequency/Duration | Control | Outcomes (Cardiac Structure/Function) | Outcomes (Exercise Capacity) |
---|---|---|---|---|---|---|---|
Palau et al. 2014[35] | 14/13 | >50% ≥II |
Recent (<3 months) ACS or cardiac surgery, pulmonary disease, smokers | 20 min/ twice a day/ 12 weeks | Usual care | E/e’, e’, EF, LV mass | Peak VO2, 6MWD |
TRAINING-HF Trial. 2019[36] | 15/13 | >50% ≥II |
Recent (<3 months) ACS or cardiac surgery, COPD | 20 min/ twice a day/ 24 weeks | Usual care | E/e’, LA volume | Peak VO2 |
6MWD = 6-minute walk distance; ACS = acute coronary syndrome; COPD = chronic obstructive pulmonary disease; E/e’ = the ratio of early diastolic mitral inflow to annular velocities; e’ = early diastolic mitral annular velocity; EF = ejection fraction; HFpEF = heart failure with preserved EF; LA = left atrial; LV = left ventricular; NYHA = New York Heart Association; peak VO2 = peak exercise oxygen uptake.